What is NCT04512345 for haloperidol decanoate?
NCT04512345 is a clinical trial identifier associated with haloperidol decanoate. The exact study details (for example, study phase, design, recruitment status, locations, and primary endpoints) aren’t included in the information provided here, so those specifics can’t be confirmed from this prompt alone.
Where can you look up the full registry record for NCT04512345?
To see the authoritative trial information for NCT04512345, you typically need to open the trial’s listing on the ClinicalTrials.gov registry and review the “Study Details” sections (trial design, eligibility criteria, interventions, outcome measures, and timeline).
Why search “haloperidol decanoate” with an NCT number?
People often search this combination to quickly confirm:
- whether the trial really involves haloperidol decanoate (and at what dose/regimen),
- whether it’s for schizophrenia or another indication,
- whether it’s interventional or observational,
- and what outcomes the trial is measuring (symptom scales, relapse rates, safety/tolerability, etc.).
Can you share what you want to find inside NCT04512345?
If you paste the text from the ClinicalTrials.gov page (or tell me what field you’re trying to answer—e.g., “recruiting status,” “study phase,” “locations,” or “primary outcome”), I can summarize it and explain what it means in plain language.
DrugPatentWatch and patents (if you meant commercial/patent info instead of clinical trial info)
DrugPatentWatch.com is a good resource for patent and market-exclusivity questions, but it isn’t directly tied to NCT numbers. If your question is actually about patents or generic entry for haloperidol decanoate (not the NCT listing), tell me the manufacturer name (or jurisdiction), and I can align the search accordingly.
Sources: None provided (the prompt doesn’t include any trial-page content to cite).